Growth Metrics

Enanta Pharmaceuticals (ENTA) Free Cash Flow (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 39.44%
Dec 31, 2025 34.17%
Sep 30, 2025 -165.67%
Jun 30, 2025 270.93%
Mar 31, 2025 37.27%
Dec 31, 2024 -16.48%
Sep 30, 2024 -17.06%
Jun 30, 2024 38.10%
Mar 31, 2024 -17.44%
Dec 31, 2023 -12.21%
Sep 30, 2023 32.99%
Jun 30, 2023 -112.04%
Mar 31, 2023 58.33%
Dec 31, 2022 -141.56%
Sep 30, 2022 46.20%
Jun 30, 2022 -11.53%
Mar 31, 2022 -100.99%
Dec 31, 2021 38.79%
Sep 30, 2021 25.51%
Jun 30, 2021 -520.17%
Mar 31, 2021 68.77%
Dec 31, 2020 1.77%
Sep 30, 2020 -228.13%
Jun 30, 2020 -131.08%
Mar 31, 2020 26.76%
Dec 31, 2019 43.96%
Sep 30, 2019 2,622.44%
Jun 30, 2019 -98.94%
Mar 31, 2019 -1.56%
Dec 31, 2018 2.30%
Sep 30, 2018 440.45%
Jun 30, 2018 160.03%
Mar 31, 2018 -302.95%
Dec 31, 2017 -92.47%
Sep 30, 2017 1,130.74%
Jun 30, 2017 -54.66%
Mar 31, 2017 -263.32%
Dec 31, 2016 40.51%
Sep 30, 2016 157.25%
Jun 30, 2016 -131.90%
Mar 31, 2016 -69.27%
Dec 31, 2015 802.81%
Sep 30, 2015 72.92%
Jun 30, 2015 -114.79%
Mar 31, 2015 1,783.62%
Dec 31, 2014 -8.29%
Sep 30, 2014 -115.60%
Jun 30, 2014 913.25%
Mar 31, 2014 27.55%
Dec 31, 2013 -117.93%
Sep 30, 2013 54.72%
Jun 30, 2013 -161.64%
Mar 31, 2013 7.28%
Dec 31, 2012 598.29%
Sep 30, 2012 53.21%